| Characteristic | 1 modality | 2 modalities | 3 modalities |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
May 2022
More information
Region
Worldwide
Survey time period
as of 2022
Number of respondents
150 major CDMOs
Supplementary notes
Data was collected from 150 of the world’s major players, classified according to the nature of their core business: pure play CDMO, PharmaCo CDMO, generics manufacturing CDMO, and pharma affiliate CDMO.
Citation formats
